Cubist Pharmaceuticals, Inc. (CBST) Posts Q4 EPS of 66c
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
U.S. product revenues, net: 291.88M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
U.S. product revenues, net: 291.88M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q4 EPS of $0.66, $0.34 better than the analyst estimate of $0.32. Revenue for the quarter came in at $213 million versus the consensus estimate of $204.74 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Pulmatrix (PULM) Reports Q2 Loss of $0.29
- Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
